SBIR/STTR Research Award

Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography

Award identifier f12971418d7506449ad4f5f1842aa1e77e6914b99258a26297a1d406ff5b554cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,752,420

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MYOLEX, INC.
Proposal award date
2022-08-01
Contract end date
2024-07-31
UEI
XMRNG2MNK6F1
Solicitation number
PA21-259
Topic code
NIA

Research abstract

Project SummaryForty-two percent of older adults (OAs) have one or more physical limitations that are essential for in- dependence. Age-related muscle wasting and weakness (sarcopenia) are important contributors to these phy- sical impairments, including most notably gait impairment. Moreover, sarcopenia is closely associated with an increased risk of falls and other injuries leading to loss of independence and increased mortality. Healthcare providers of OAs need improved means of evaluating lower extremity muscle condition for the development of sarcopenia. MRI, CT, and DXA provide considerable information, but none are office-based and DXA only provides information on lean body mass and fat content. In this application, we advance electrical impedance myography (EIM) for assessment of lower extremity muscle condition in OAs. EIM relies upon application of directionally focused, multi-frequency electrical current to specific muscles or muscle groups. By applying the technology in such a localized fashion, it is virtually unaffected by hydration status or other issues that commonly impact other bioimpedance-based methods. EIM has been studied for nearly two decades in the field of neuromuscular disease and has been shown to be sensitive to a variety of alterations in skeletal muscle including atrophy, degeneration, and simple deconditioning. Taking EIM one step further and applying machine learning (ML) techniques to the complex multifrequency EIM data set, it even becomes possible to predict histological features, including myofiber size, fat, and connective tissue content. Given this demonstrated capability, EIM has the potential to serve as a convenient, office-based approach for assessing muscle health in OAs. In this direct-to-Phase 2 SBIR application, Myolex proposes to establish EIM, via its new device, the mScan, in conjunction with machine learning cloud-based platform, as a means of obtaining MRI-like quantitative data in muscle of OAs. In Specific Aim 1, in conjunction with aging expert researchers at 3 different clinical sites, we will collect MRI and EIM data on a cohort of healthy older adults, along with standard functional measures as well as measuring specific force, via electrically stimulated muscle contraction. Using this data, in Specific Aim 2, we will develop predictive algorithms, via the penalized regression technique of Lasso (least absolute shrinkage and selection operator), leveraging EIM values to predict muscle volume, muscle specific force, and muscle fatty infiltration. We will then incorporate these algorithms into a cloud-based engine that will provide meaningful, easy-to-interpret values. At the conclusion of this proposed work, we will have developed an accurate, powerful system that clinicians and researchers can use for the rapid assessment of OA muscle health.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

16 SBIR/STTR records share this UEI (2010–2025). Reported award amounts total $14,437,590. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.